Concepedia

Author

Kazunori Samata

Taisho Pharmaceutical (Japan)

Also Known As

Kazunori Samata

10

Publications

159

Citations

8

H-Index

26

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)
KS

About

Kazunori Samata is an author at Taisho Pharmaceutical (Japan) specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

102

2

Cell Biology

2

2

26

3

Natural Sciences

1

1

22

4

Biomolecular Engineering

1

1

22

5

Immunology

1

1

22

Kazunori Samata

×

6

Publications

133

Citations

6

H-Index

YearCitations

Chemical removal of the endothelium by saponin in the isolated dog femoral artery

Kazunori Samata, Tomohiko Kimura, Susumu Satoh,

European Journal of Pharmacology

1986

39

Mechanism of action of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G1 phase of the cell cycle

Kazuya Fukuoka, Takehiro Yamagishi, Tomoko Ichihara,

International Journal of Cancer

2000

31

A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155.

Yasuji Ueda, Takehiro Yamagishi, Kazunori Samata,

PubMed

2003

22

In vivo activity on murine tumors of a novel antitumor compound, N-?-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190)

Shiro Nakaike, Takehiro Yamagishi, Kazunori Samata,

Cancer Chemotherapy and Pharmacology

1989

15

VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.

Yasuji Ueda, Takehiro Yamagishi, Hisao Ikeya,

PubMed

2004

15

A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growth

Yasuji Ueda, Takehiro Yamagishi, Kazunori Samata,

Cancer Chemotherapy and Pharmacology

2004

11

Page 1